TB Alliance Applauds Innovative, International Effort to Fund New Drugs
FOR IMMEDIATE RELEASE Global Alliance for TB Drug Development Applauds Innovative, International Effort to Fund New Drugs ‘UNITAID’ Announces Funding
FOR IMMEDIATE RELEASE Global Alliance for TB Drug Development Applauds Innovative, International Effort to Fund New Drugs ‘UNITAID’ Announces Funding
Licensing Executive Society Awards the “Deal of Distinction” Prize for Top Licensing Agreement in the Industry-University-Government Category NEW YORK CITY
TB Alliance Applauds Actions by Health Leaders on XDR-TB and Says More Resources are Needed to Speed Development of New
The TB Alliance announced on May 25 that it is receiving $104 million from the Bill & Melinda Gates Foundation
Three Grants Announced at Columbia University Symposium Tracking Progress in Battle Against Disease Infecting One-Third of the World NEW YORK
Project Aims to Streamline and Shorten Drug Development for Tuberculosis New York, NY and Waltham, MA., February 21, 2006 –
At its October 2005 Board Meeting, the TB Alliance Board of Directors appointed two new Board members to three-year terms:
Bayer Healthcare AG has signed an agreement with the Global Alliance for TB Drug Development to study whether the quinolone
NEW YORK CITY (July 5, 2005) — The TB Alliance announced the appointment of Ms. Nina Schwalbe as Director of
Trial is First in TB Alliance’s Growing Pipeline of Drugs — Provides Model for Future Drug Development NEW YORK CITY